Pretreatment of Hepatocyte Growth Factor Gene Transfer Mediated by Octaarginine Peptide-Modified Nanoparticles Ameliorates LPS/D-Galactosamine-Induced Hepatitis-Reference-Cited by-同舟云学术

Pretreatment of Hepatocyte Growth Factor Gene Transfer Mediated by Octaarginine Peptide-Modified Nanoparticles Ameliorates LPS/D-Galactosamine-Induced Hepatitis

Published:2012-10 Issue:5 Volume:22 Page:360-363
ISSN:2159-3337
Container-title:Nucleic Acid Therapeutics
language:en
Short-container-title:Nucleic Acid Therapeutics

Author:

Hayashi Yasuhiro¹,Mizuno Ryoichi²,Ikramy Khalil A.³,Akita Hidetaka²,Harashima Hideyoshi¹²

Affiliation:

1. Laboratory of Innovative Nanomedicine, Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo, Hokkaido, Japan.

2. Laboratory for Molecular Design of Pharmaceutics, Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo, Hokkaido, Japan.

3. Department of Pharmaceutics, Faculty of Pharmacy, Assiut University, Assiut, Egypt.

Publisher

Mary Ann Liebert Inc

Subject

Drug Discovery,Genetics,Molecular Biology,Molecular Medicine,Biochemistry

Link

http://www.liebertpub.com/doi/pdf/10.1089/nat.2012.0352

Reference14 articles.

1. Improving in Vivo Hepatic Transfection Activity by Controlling Intracellular Trafficking: The Function of GALA and Maltotriose

2. Non-viral gene delivery using nanoparticles

3. Stimulation of liver growth by exogenous human hepatocyte growth factor in normal and partially hepatectomized rats

4. Fulminant hepatic failure: Summary of a workshop*1

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. General Targeting Strategies;CPP, Cell-Penetrating Peptides;2023

2. CPP Functionalized Nanoparticles;CPP, Cell-Penetrating Peptides;2023

3. Lipid‐Based Nanoparticles Using Cell‐Penetrating Peptides;Cell‐Penetrating Peptides;2022-12-02

4. Robust delivery of RIG‐I agonists using extracellular vesicles for anti‐cancer immunotherapy;Journal of Extracellular Vesicles;2022-04

5. Synthetic mRNA Gene Therapies and Hepatotropic Non-viral Vectors for the Treatment of Chronic HBV Infections;RNA Technologies;2022